Temodar 250 MG Oral Capsule

RxCUI: 261291
RxNorm name: Temodar 250 MG Oral Capsule
Display name: Temodar 250 MG Oral Capsule
Full name: Temodar 250 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TEMODAR	TEMOZOLOMIDE	Merck Sharp & Dohme LLC	046a9011-3911-4d3f-a15f-fbb56d5aad56	2026-02-20	Warnings, Adverse reactions	Exact identifier rxcui: 261291

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
046a9011-3911-4d3f-a15f-fbb56d5aad56	Temodar 250 MG Oral Capsule [PSN] · temozolomide 250 MG Oral Capsule [Temodar] [SBD] · Temodar 250 MG Oral Capsule [SY]	3	40	These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR ® (temozolomide) capsules, for oral use TEMODAR ® (temozolomide) for injection, for intravenous use Initial U.S. Approval: 1999	20260220
819571ea-b808-4fd8-93c7-1ea2e33d71cf	Temodar 250 MG Oral Capsule [PSN] · temozolomide 250 MG Oral Capsule [Temodar] [SBD] · Temodar 250 MG Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) Capsules TEMODAR (temozolomide) for Injection administered via intravenous infusion Initial U.S. Approval: 1999	20110209